1Ohya S,Fukuoka T,Masuda N,et al.Microbiological evaluation of panipenem/betamipron,a new parenterally active carlapenem V.increase in susceptibility of pseudomonas aeruginosa to panipenem in low.amino-acid media.Chemo Therapy,1991,39(S-3):132
2Levy SB.The Challenge of antibiotic resistance[J].Scientific American,1998,278:46-53
3Jones RN,Pfaller MA.Bacterial resistance: A worldwide problem[J].Diagn.Microbiol Infect Dis,1998,31:379-388
4Williams RJ,Ryan MJ.Surveillance of antimicrobial resistance-an international perspective[J].Br Med J,1998,317:651
5Am Society Microbiol.Report of the ASM task force on antibiotic resistance[J].Antimicrob Agents,Chemother,1995,Supplement: 1-23
6World Health Organization.WHO global strategy for containment of antimicrobial resistance.WHO/CDS/CSR/DRS/2001.2[J]
7Wang H,Huebner R,Chen M,et al.Antibiotic susceptibility patterns of Streptococcus pneumoniae in China and comparison of MICs by agar dilution and E test methods[J].Antimicrob Agents Chemother,1998,42:2633-2636
8Sahm DF,Karlowsky JA,Kelly LJ,et al.Need for annual surveillance of antimicrobial resistance in Streptococcus pneumoniae in the United States:2-year longitudinal analysis[J].Antimicrob Agents Chemother,2001,45:1037-1042
9Xiong Z,Zhu D,Wang F,et al.Investigation of extended spectrum β-lactamases in Klebsiella pneumoniae and Escherichia coli from China.(to be published)
10Coudron PE,Moland ES,Sanders CC.Occurrence and detection of extended-spectrum β-lactamases in members of the family Enterobacteriaceae at a veterans medical center:seek and you may find[J].J Clin Microbiology,1997,35:2593-2597
